Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors

BACKGROUND: Targeted therapy has been established as the standard-of-care for patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. Among patients with advanced lung cancer, 30–40% have bone metastases (BoM) at first diagnosis. However, lit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Bone Oncol
Main Authors: Chen, Yue-Yun, Wang, Pei-Pei, Fu, Yang-, Li, Qing-, Tian, Jiang-Fang, Liu, Ting-, Lin, Zhen, Ding, Zhen-Yu
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2021
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8138759/
https://ncbi.nlm.nih.gov/pubmed/34036039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100369
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares